Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 10, 1999

View Archived Issues

Increasingly Global Market Helps Bridge Atlantic Divide

UK, Italian Researchers Seek Role Of Infection In Leukemia

PPL Reduces Staff By 80 As Program Delays Force Cuts

Genset, Energy Commission Align In Genotyping Project

Evax Completes DM16M Round For 'Bacterial Ghost' Vaccines

Other News To Note

Devgen Enters Collaboration In Pesticides With FMC Unit

Wilex Implements Plan For Trials Of Cancer Antibody

Europe, U.S. Close WTO Gap On Issues Related To Biotech

Peptech Gains On News That TNF Patent Upheld In Europe

XTL Gets Footing In U.S. Through New Subsidiary

Pharming Plans Extension Of Phase II In Pompe's Disease

Biotrin's TAP Product Performs Well In Acute Pancreatitis Study

Ontario Creates C$20M Fund To Boost Biotech In Province

Qiagen, Affymetrix Agree To Develop Nucleic Acid Solutions

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...